These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3873711)

  • 1. [Studies of the mechanisms of human B-cell activation. II. The role of resting B-cell abnormalities in the pathogenesis of systemic lupus erythematosus].
    Ueda Y; Sakane T; Suzuki N; Takada S; Murakawa Y; Tsunematsu T; Niwa Y; Tsuchiya T
    Ryumachi; 1985 Feb; 25(1):8-14. PubMed ID: 3873711
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation and immunoregulation of human B lymphocyte function: implications in normal and disease states.
    Fauci AS
    Monogr Allergy; 1983; 18():96-105. PubMed ID: 6358871
    [No Abstract]   [Full Text] [Related]  

  • 3. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
    Günther W; Diezel W; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
    [No Abstract]   [Full Text] [Related]  

  • 4. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
    Bowen DL; Fauci AS
    J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of regulatory factors in human antibody secretion.
    Peters M; MacDermott RP
    Year Immunol; 1986; 2():134-44. PubMed ID: 3554820
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of human B cell activation by diterpine forskolin: interference with B cell growth factor-induced G1 to S transition of the B cell cycle.
    Muraguchi A; Miyazaki K; Kehrl JH; Fauci AS
    J Immunol; 1984 Sep; 133(3):1283-7. PubMed ID: 6086754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diacetyl diamines on in vitro activation and proliferation of human B lymphocytes.
    Lacy J; Summers WC; Canellakis ZN
    J Immunol; 1985 Dec; 135(6):3772-6. PubMed ID: 3877754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth and differentiation factors for B cells from human T cell clones.
    Okada M; Shimizu K; Kaieda T; Yoshizaki K; Kishimoto T
    Lymphokine Res; 1983; 2(4):113-8. PubMed ID: 6236342
    [No Abstract]   [Full Text] [Related]  

  • 9. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus.
    Saiki O; Saeki Y; Kishimoto S
    J Clin Invest; 1985 Nov; 76(5):1865-70. PubMed ID: 3932473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
    Gandzha IM; Sakharchuk VM; Lysenko GI
    Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
    Hostmann A; Jacobi AM; Mei H; Hiepe F; Dörner T
    Lupus; 2008 Dec; 17(12):1064-9. PubMed ID: 19029273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of the mechanisms of human B-cell activation. IV. Abnormalities at the B-cell level in patients with Behçet's disease].
    Suzuki N; Sakane T; Takada S; Ueda Y; Murakawa Y; Tsunematsu T; Tsuchiya T; Niwa Y
    Ryumachi; 1985 Apr; 25(2):95-102. PubMed ID: 3875902
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of interleukin 1 on human B cell activation and proliferation.
    Falkoff RJ; Muraguchi A; Hong JX; Butler JL; Dinarello CA; Fauci AS
    J Immunol; 1983 Aug; 131(2):801-5. PubMed ID: 6602846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Function and significance of B-lymphocyte defects in the pathogenesis of systemic lupus erythematosus].
    Wollina U
    Dermatol Monatsschr; 1984; 170(2):81-90. PubMed ID: 6202566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of the mechanisms of human B cell activation. III. Development of an assay system for human B cell differentiation factors (BCDF) and identification of BCDF-producing T cell subsets].
    Suzuki N; Sakane T; Ueda Y; Takada S; Murakawa Y; Tsunematsu T; Tsuchiya T; Niwa Y
    Arerugi; 1984 Nov; 33(11):963-9. PubMed ID: 6335652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies on accessory function of B cells].
    Nagayoshi T
    Fukuoka Igaku Zasshi; 1987 Feb; 78(2):82-94. PubMed ID: 3034752
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of the mechanisms of human B cell activation. I. Development of an assay system for human B cell growth factors (BCGF) and identification of BCGF-producing T cell subsets].
    Ueda Y; Sakane T; Suzuki N; Takada S; Murakawa Y; Tsunematsu T; Niwa Y; Tsuchiya T
    Arerugi; 1984 Oct; 33(10):859-67. PubMed ID: 6335391
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells.
    Grimaldi CM
    Curr Opin Rheumatol; 2006 Sep; 18(5):456-61. PubMed ID: 16896282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OKT4+ and OKT8+ T lymphocytes produce soluble factors that can modulate growth and differentiation of human B cells.
    Sakane T; Ueda Y; Suzuki N; Niwa Y; Hoshino T; Tsunematsu T
    Clin Exp Immunol; 1985 Oct; 62(1):112-20. PubMed ID: 3933868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lymphocyte population in systemic lupus erythematosus].
    Del Pozo Pérez MA; Prieto Valtueña J; González Guilabert MI; Velasco Alonso R
    Rev Clin Esp; 1975 Mar; 136(6):527-30. PubMed ID: 1079620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.